Hologic, Inc. (0J5Q.L)
USD 58.38
(1.81%)
USD 58.38
(1.81%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 2.23 Billion USD | -9.82% |
| 2023 | 2.48 Billion USD | -16.44% |
| 2022 | 2.96 Billion USD | -20.89% |
| 2021 | 3.75 Billion USD | 69.57% |
| 2020 | 2.21 Billion USD | 30.4% |
| 2019 | 1.69 Billion USD | 3.68% |
| 2018 | 1.63 Billion USD | 5.06% |
| 2017 | 1.55 Billion USD | 5.76% |
| 2016 | 1.47 Billion USD | -14.94% |
| 2015 | 1.73 Billion USD | 9.16% |
| 2014 | 1.58 Billion USD | 3.75% |
| 2013 | 1.52 Billion USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 554.2 Million USD | 12.16% |
| 2024 Q2 | 562.5 Million USD | 1.5% |
| 2024 Q3 | 618 Million USD | 9.87% |
| 2024 Q4 | 552.8 Million USD | -10.55% |
| 2023 FY | 2.22 Billion USD | -25.14% |
| 2023 Q2 | 578.7 Million USD | -5.18% |
| 2023 Q1 | 610.3 Million USD | 19.46% |
| 2023 Q4 | 494.1 Million USD | -8.48% |
| 2023 Q3 | 539.9 Million USD | -6.7% |
| 2022 Q1 | 975.5 Million USD | 19.46% |
| 2022 FY | 2.96 Billion USD | -20.89% |
| 2022 Q4 | 510.9 Million USD | -5.14% |
| 2022 Q3 | 538.6 Million USD | -42.41% |
| 2022 Q2 | 935.3 Million USD | -4.12% |
| 2021 FY | 3.75 Billion USD | 69.57% |
| 2021 Q3 | 691.2 Million USD | -39.91% |
| 2021 Q4 | 816.6 Million USD | 18.14% |
| 2021 Q1 | 1.24 Billion USD | 23.9% |
| 2021 Q2 | 1.15 Billion USD | -7.38% |
| 2020 Q3 | 529 Million USD | 15.33% |
| 2020 Q4 | 1 Billion USD | 89.49% |
| 2020 FY | 2.21 Billion USD | 30.4% |
| 2020 Q1 | 523.2 Million USD | -2.99% |
| 2020 Q2 | 458.7 Million USD | -12.33% |
| 2019 FY | 1.69 Billion USD | 3.68% |
| 2019 Q4 | 539.3 Million USD | 3.04% |
| 2019 Q3 | 523.4 Million USD | 5.23% |
| 2019 Q1 | 516.9 Million USD | 2.87% |
| 2019 Q2 | 497.4 Million USD | -3.77% |
| 2018 Q2 | 494.9 Million USD | -1.86% |
| 2018 Q3 | 515.4 Million USD | 4.14% |
| 2018 Q4 | 502.5 Million USD | -2.5% |
| 2018 FY | 1.63 Billion USD | 5.06% |
| 2018 Q1 | 504.3 Million USD | -1.96% |
| 2017 Q2 | 456.3 Million USD | -4.6% |
| 2017 FY | 1.55 Billion USD | 5.76% |
| 2017 Q3 | 508.3 Million USD | 11.4% |
| 2017 Q1 | 478.3 Million USD | 0.21% |
| 2017 Q4 | 514.4 Million USD | 1.2% |
| 2016 Q4 | 477.3 Million USD | 1.34% |
| 2016 Q1 | 452.5 Million USD | -0.22% |
| 2016 Q2 | 455.8 Million USD | 0.73% |
| 2016 Q3 | 471 Million USD | 3.33% |
| 2016 FY | 1.47 Billion USD | -14.94% |
| 2015 Q4 | 453.5 Million USD | 0.38% |
| 2015 FY | 1.73 Billion USD | 9.16% |
| 2015 Q2 | 414.6 Million USD | 0.51% |
| 2015 Q1 | 412.5 Million USD | -3.06% |
| 2015 Q3 | 451.8 Million USD | 8.97% |
| 2014 Q1 | 382.3 Million USD | 1.19% |
| 2014 FY | 1.58 Billion USD | 3.75% |
| 2014 Q3 | 393.3 Million USD | 2.0% |
| 2014 Q2 | 385.6 Million USD | 0.86% |
| 2014 Q4 | 425.5 Million USD | 8.19% |
| 2013 Q1 | 386.83 Million USD | 0.0% |
| 2013 Q4 | 377.8 Million USD | -2.5% |
| 2013 Q3 | 387.5 Million USD | 2.63% |
| 2013 Q2 | 377.55 Million USD | -2.4% |
| 2013 FY | 1.52 Billion USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Phreesia, Inc. | 201.74 Million USD | -1009.222% |
| Accuray Incorporated | 143.12 Million USD | -1463.572% |
| Align Technology, Inc. | 2.72 Billion USD | 17.733% |
| Elevance Health Inc. | 47.01 Billion USD | 95.24% |
| AxoGen, Inc. | 127.87 Million USD | -1650.004% |
| Boston Scientific Corporation | 9.84 Billion USD | 77.279% |
| CVS Health Corporation | 54.43 Billion USD | 95.889% |
| Cardinal Health, Inc. | 7.41 Billion USD | 69.817% |
| Centene Corporation | 153.99 Billion USD | 98.547% |
| DaVita Inc. | 3.82 Billion USD | 41.425% |
| HCA Healthcare, Inc. | 55.06 Billion USD | 95.936% |
| Humana Inc. | 106.44 Billion USD | 97.898% |
| IDEXX Laboratories, Inc. | 2.18 Billion USD | -2.184% |
| Laboratory Corporation of America Holdings | 3.36 Billion USD | 33.496% |
| Masimo Corporation | 1 Billion USD | -123.0% |
| McKesson Corporation | 12.58 Billion USD | 82.217% |
| Patterson Companies, Inc. | 1.38 Billion USD | -62.131% |
| Quest Diagnostics Incorporated | 2.96 Billion USD | 24.424% |
| ResMed Inc. | 2.6 Billion USD | 14.221% |
| Henry Schein, Inc. | 3.65 Billion USD | 38.707% |
| Teladoc Health, Inc. | 1.84 Billion USD | -21.462% |
| Universal Health Services, Inc. | 1.17 Billion USD | -90.389% |
| Veeva Systems Inc. | 1.68 Billion USD | -32.698% |
| Baxter International Inc. | 4.97 Billion USD | 55.019% |
| Becton, Dickinson and Company | 8.82 Billion USD | 74.637% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 52.684% |
| Danaher Corporation | 14.12 Billion USD | 84.162% |
| Stryker Corporation | 13.05 Billion USD | 82.863% |
| Medtronic plc | 21.27 Billion USD | 89.481% |